Moderna sues Pfizer and BioNTech for mRNA patent infringement

CAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent infringement lawsuits against both Pfizer ($262.8 billion market capital) and BioNTech (market capital of $34.6 billion) in the United States District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany […]

The FDA approves Moderna’s “Spikevax” vaccine

Yesterday, the Food and Drug Administration approved Moderna’s COVID-19 vaccine for individuals 18 years of age and older. Upon approval, the Moderna vaccine will be marketed as “Spikevax.” The Emergency Use Authorization (EUA) of Moderna’s COVID-19 vaccine will remain in place for individuals 18 years of age and older. “The FDA’s approval of Spikevax is […]